Product Code: GVR-4-68040-306-1
U.S. Remote Patient Monitoring System Market Growth & Trends:
The U.S. remote patient monitoring system market size is anticipated to reach USD 6.3 billion by 2030, growing at a CAGR of 18.4% during the forecast period, according to a new report by Grand View Research, Inc. The increasing incidence of chronic diseases, such as diabetes, hypertension, and heart diseases has led to a higher demand for remote patient monitoring systems. These systems help manage chronic conditions more effectively, reducing hospitalizations and improving patient outcomes.
The U.S. healthcare system is moving towards value-based care, which emphasizes better patient outcomes and cost efficiency. Remote patient monitoring systems align with this shift, as they help reduce healthcare costs and improve patient outcomes. Remote patient monitoring systems enable early detection of health issues, allowing for timely interventions and better preventive care. This has led to increased adoption of these systems in the U.S. market.
According to the Centers for Disease Control and Prevention (CDC), in 2021, hypertension was a primary or one of the major contributing causes of the 691,095 deaths in the U.S. The treatment of chronic diseases such as diabetes and hypertension require routine testing and monitoring, due to which, these remote patient monitoring devices are needed. The incensing cases of diabetes in the U.S., in turn, drives the demand of these devices.
U.S. Remote Patient Monitoring System Market Report Highlights:
- Specialized monitors dominated the product segment with more than 80.0% share in 2023 owing to their specific parameters with greater accuracy compared to the general devices
- The vital sign monitors product segment is expected to grow at the fastest CAGR over the forecast period
- The diabetes application segment held the largest market share in 2023. Diabetic patients often need to monitor their blood glucose levels multiple times a day to maintain optimal control
- The sinus infections application segment accounted for the largest market share in 2023, owing to their complications and significant role played by remote patient monitoring systems in diagnosing and preventing further infection
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Infection
- 1.2.4. End-use
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product
- 2.2.2. Application
- 2.2.3. Infection
- 2.2.4. End-use
- 2.3. Competitive Insights
Chapter 3. U.S. Remote Patient Monitoring System Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising incidence of diseases such as diabetes
- 3.2.1.2. Technological advancements in healthcare
- 3.2.2. Market restraint analysis
- 3.2.2.1. Stringent regulations & approvals
- 3.3. U.S. Remote Patient Monitoring System Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. U.S. Remote Patient Monitoring System Market: Product Estimates & Trend Analysis
- 4.1. Product Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. U.S. Remote Patient Monitoring System Market by Product Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. Vital sign monitors
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.2. Blood pressure monitors
- 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.3. Pulse oximeters
- 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.4. Heart rate monitor (ECG)
- 4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.5. Temperature monitor
- 4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.6. Respiratory rate monitor
- 4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1.7. Brain monitoring (EEG)
- 4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Specialized monitors
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.2. Anesthesia monitors
- 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.3. Blood glucose monitors
- 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.4. Cardiac rhythm monitor
- 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.5. Respiratory monitor
- 4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.6. Fetal heart monitors
- 4.4.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.7. Prothrombin monitors
- 4.4.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.8. Multi parameter monitors (MPM)
- 4.4.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2.9. Others (Ventilators, Infusion Pumps and others)
- 4.4.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Remote Patient Monitoring System Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. U.S. Remote Patient Monitoring System Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Cancer
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Cardiovascular diseases
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Diabetes
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Sleep disorder
- 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Weight management and fitness monitoring
- 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.6. Bronchitis
- 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.7. Infections
- 5.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.8. Virus
- 5.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.9. Dehydration
- 5.4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.10. Hypertension
- 5.4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Remote Patient Monitoring System Market: Infection Estimates & Trend Analysis
- 6.1. Infection Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. U.S. Remote Patient Monitoring System Market by Infection Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Eye infections
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Sinus infections
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Strep throat
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Remote Patient Monitoring System Market: End-use Estimates & Trend Analysis
- 7.1. End-use Market Share, 2023 & 2030
- 7.2. Segment Dashboard
- 7.3. U.S. Remote Patient Monitoring System Market by End-use Outlook
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 7.4.1. Hospital-based patients
- 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Ambulatory patients
- 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Home healthcare
- 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company heat map analysis, 2023
- 8.4. Company Profiles
- 8.4.1. Welch Allyn
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Smiths Medical
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Abbott
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Boston Scientific Corporation
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Drager Medical
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. GE Healthcare
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Honeywell
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Johnson & Johnson
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. LifeWatch
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Medtronic
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives